Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for central retinal vein occlusion with macular edema has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and medical devices. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
201 publications have been identified in PubMed for central retinal vein occlusion with macular edema. Kisho has analyzed 82 by research type. Research spans Review / Meta-Analysis (28%), Epidemiology / Natural History (26%), and Clinical Trial Publication (21%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 23 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 2:32 PM UTC
28%
Disease patterns and progression | 21 | 26% |
Clinical study results | 17 | 21% |
Testing and diagnosis research | 10 | 12% |
New treatment approaches | 5 | 6% |
Patient case studies | 4 | 5% |
Other research | 1 | 1% |
Laboratory research | 1 | 1% |
Kim M (2026). [PMID: 41570274](https://pubmed.ncbi.nlm.nih.gov/41570274/). *Retina*. [Epidemiology / Natural History]
Mir TA (2026). [PMID: 42217978](https://pubmed.ncbi.nlm.nih.gov/42217978/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Suresh B (2026). [PMID: 35881741](https://pubmed.ncbi.nlm.nih.gov/35881741/). *Unknown Journal*. [Gene Therapy / Novel Therapeutics]
Vaidyanathan U (2026). [PMID: 31335082](https://pubmed.ncbi.nlm.nih.gov/31335082/). *Unknown Journal*. [Gene Therapy / Novel Therapeutics]
Khilji M (2026). [PMID: 41698436](https://pubmed.ncbi.nlm.nih.gov/41698436/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Temkar S (2026). [PMID: 42054088](https://pubmed.ncbi.nlm.nih.gov/42054088/). *Indian J Ophthalmol*. [Review / Meta-Analysis]
Cicinelli MV (2026). [PMID: 40987400](https://pubmed.ncbi.nlm.nih.gov/40987400/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Hikichi T (2026). [PMID: 40694284](https://pubmed.ncbi.nlm.nih.gov/40694284/). *Jpn J Ophthalmol*. [Epidemiology / Natural History]
Singh S (2026). [PMID: 42060352](https://pubmed.ncbi.nlm.nih.gov/42060352/). *Indian J Ophthalmol*. [Review / Meta-Analysis]
Lakhani M (2026). [PMID: 40902799](https://pubmed.ncbi.nlm.nih.gov/40902799/). *Ophthalmol Retina*. [Epidemiology / Natural History]